• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌营养不良蛋白在缺乏肌营养不良蛋白的小鼠中作为移植排斥抗原:对基因治疗的启示。

Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.

作者信息

Ohtsuka Y, Udaka K, Yamashiro Y, Yagita H, Okumura K

机构信息

Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

J Immunol. 1998 May 1;160(9):4635-40.

PMID:9574572
Abstract

Duchenne muscular dystrophy is a lethal and common X-linked recessive disease caused by a defect in dystrophin. Normal myoblast transplantation and dystrophin gene transfer have been expected to correct the deficiency in the muscles, but their clinical application has been hampered by the limited preservation of dystrophin-positive myofibers. In this study we investigated the mechanism for immunologic rejection of normal C57BL/10 (B10) myoblasts transplanted into dystrophin-deficient mdx mice, an animal model of Duchenne muscular dystrophy. We found that mdx mice develop CTL specific for dystrophin itself, which were CD8 dominant and restricted by H-2Kb. We identified several antigenic peptides derived from dystrophin that bind to H-2Kb and are recognized by the mdx anti-B10 CTL. Immunologic tolerance against dystrophin was successfully induced by i.v. injection of these peptides before B10 myoblast transplantation, which resulted in sustained preservation of dystrophin-expressing myofibers in mdx mice. These results demonstrate that dystrophin is antigenic in dystrophin-deficient mice and that immunologic regimen would be necessary to achieve the persistent expression of introduced dystrophin in the muscles of dystrophin-deficient individuals.

摘要

杜兴氏肌营养不良症是一种由肌营养不良蛋白缺陷引起的常见致死性X连锁隐性疾病。正常成肌细胞移植和肌营养不良蛋白基因转移有望纠正肌肉中的缺陷,但它们的临床应用因肌营养不良蛋白阳性肌纤维的保存有限而受到阻碍。在本研究中,我们调查了将正常C57BL/10(B10)成肌细胞移植到杜兴氏肌营养不良症动物模型——肌营养不良蛋白缺陷的mdx小鼠体内时免疫排斥的机制。我们发现mdx小鼠产生了针对肌营养不良蛋白本身的细胞毒性T淋巴细胞(CTL),这些CTL以CD8为主且受H-2Kb限制。我们鉴定了几种源自肌营养不良蛋白的抗原肽,它们与H-2Kb结合并被mdx抗B10 CTL识别。在B10成肌细胞移植前通过静脉注射这些肽成功诱导了对肌营养不良蛋白的免疫耐受,这导致mdx小鼠中持续保存表达肌营养不良蛋白的肌纤维。这些结果表明,肌营养不良蛋白在肌营养不良蛋白缺陷小鼠中具有抗原性,并且免疫方案对于在肌营养不良蛋白缺陷个体的肌肉中实现导入的肌营养不良蛋白的持续表达是必要的。

相似文献

1
Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.肌营养不良蛋白在缺乏肌营养不良蛋白的小鼠中作为移植排斥抗原:对基因治疗的启示。
J Immunol. 1998 May 1;160(9):4635-40.
2
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.腺相关病毒载体介导的基因转移至缺乏抗肌萎缩蛋白的骨骼肌中会引发针对转基因产物的免疫反应增强。
Gene Ther. 2002 Dec;9(23):1576-88. doi: 10.1038/sj.gt.3301829.
3
Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.使用腺病毒介导的全长抗肌萎缩蛋白递送至营养不良肌肉的体外基因转移。
Gene Ther. 1998 Jan;5(1):19-30. doi: 10.1038/sj.gt.3300549.
4
Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.通过逆转录病毒产生细胞移植对成年MDX小鼠进行肌营养不良蛋白缺陷的基因校正和骨骼肌重塑。
J Clin Invest. 1997 Aug 1;100(3):620-8. doi: 10.1172/JCI119573.
5
Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.同基因全加一免疫:一种在无效突变条件下鉴定缺失蛋白质的模型。来自正常同基因供体的肌肉移植后mdx小鼠中抗肌营养不良蛋白的抗体。
Neuropediatrics. 1994 Aug;25(4):176-82. doi: 10.1055/s-2008-1073019.
6
Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.辅助性(CD4(+))和细胞毒性(CD8(+))T细胞会促进肌营养不良蛋白缺乏的肌肉的病变。
Clin Immunol. 2001 Feb;98(2):235-43. doi: 10.1006/clim.2000.4966.
7
Normal myoblast implantation in MDX mice prevents muscle damage by exercise.正常成肌细胞植入MDX小鼠可预防运动引起的肌肉损伤。
Biochem Biophys Res Commun. 1998 Sep 18;250(2):321-7. doi: 10.1006/bbrc.1998.9276.
8
Myoblast transfer and gene therapy in muscular dystrophies.成肌细胞移植与基因治疗在肌营养不良症中的应用
Microsc Res Tech. 1995 Apr 15;30(6):469-79. doi: 10.1002/jemt.1070300604.
9
Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.用单纯疱疹病毒1型扩增载体进行基因校正的mdx成肌细胞在mdx小鼠中的自体移植。
Cell Transplant. 2002;11(8):759-67.
10
A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse.一种基于聚合酶链反应的检测转入mdx小鼠体内野生型抗肌萎缩蛋白基因的方法。
Muscle Nerve. 1992 Oct;15(10):1133-7. doi: 10.1002/mus.880151012.

引用本文的文献

1
Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.Morpholino 诱导的外显子跳跃刺激 mdx 小鼠中的细胞介导和体液反应对肌营养不良蛋白。
J Pathol. 2019 Jul;248(3):339-351. doi: 10.1002/path.5263. Epub 2019 Apr 16.
2
Gene Therapy for Duchenne muscular dystrophy.杜氏肌营养不良症的基因治疗
Expert Opin Orphan Drugs. 2015;3(11):1255-1266. doi: 10.1517/21678707.2015.1088780. Epub 2015 Oct 6.
3
Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.
使用腺相关病毒载体的杜氏肌营养不良症基因替代疗法。
Curr Gene Ther. 2012 Jun;12(3):139-51. doi: 10.2174/156652312800840603.
4
Expression of dog microdystrophin in mouse and dog muscles by gene therapy.基因治疗在小鼠和犬肌肉中表达犬微小肌营养不良蛋白。
Mol Ther. 2010 May;18(5):1002-9. doi: 10.1038/mt.2010.23. Epub 2010 Feb 23.
5
Emerging strategies for cell and gene therapy of the muscular dystrophies.肌肉萎缩症细胞和基因治疗的新兴策略。
Expert Rev Mol Med. 2009 Jun 25;11:e18. doi: 10.1017/S1462399409001100.
6
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.通过重组腺相关病毒6型递送微营养蛋白可延长肌营养不良性肌营养不良蛋白/抗肌萎缩蛋白缺陷小鼠的寿命并改善其肌肉功能。
Mol Ther. 2008 Sep;16(9):1539-45. doi: 10.1038/mt.2008.149. Epub 2008 Jul 29.
7
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.用于治疗肌肉萎缩症的病毒介导基因疗法:成功、局限与最新进展
Biochim Biophys Acta. 2007 Feb;1772(2):243-62. doi: 10.1016/j.bbadis.2006.09.007. Epub 2006 Sep 26.
8
Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.杜氏肌营养不良症的治疗方法:当前进展与未来方向
J Mol Med (Berl). 2004 Feb;82(2):102-15. doi: 10.1007/s00109-003-0484-1. Epub 2003 Dec 12.
9
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.小鼠中一种新型肌肉干细胞群的鉴定:肌肉再生的潜力。
J Cell Biol. 2002 May 27;157(5):851-64. doi: 10.1083/jcb.200108150. Epub 2002 May 20.
10
Pharmacologic and genetic therapy for childhood muscular dystrophies.儿童肌营养不良的药物治疗和基因治疗
Curr Neurol Neurosci Rep. 2001 Mar;1(2):168-74. doi: 10.1007/s11910-001-0013-y.